Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In 2025 the firm added bio‑similar R&D partnerships targeting chronic conditions
2T Merchant fees IDR 1
If suppliers control unique technology or materials vital for Equillium's drug development
Margins are high: incremental operating cost per additional K-1 drops below $2 at scale
GRAB SWOT ANALYSIS TEMPLATE RESEARCH Media & Entertainment In 2025 the firm addedYour Strategic Toolkit Starts Here Grab's rapid regional expansion, integrated super app model, and strong brand give it clear advantages, but regulatory hurdles, thin ride hailing margins, and competitive pressure from Gojek and SEA present real risks; our full SWOT unpacks these dynamics with financial context and strategic actions. Purchase the complete SWOT analysis to get a professionally formatted, editable Word and Excel package that powers
US$ 11.70
US$ 112.00
US$ 20.26
